These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 help the strategy of concentrating on ACKR3 as a unique solution to modulate the opioid method, which could open new therapeutic avenues for opioid-relevant Conditions.The location is protected. The https: